The MHRA states that patients currently treated privately with the 2.4mg once-weekly semaglutide injection can be transitioned straight to semaglutide 25mg tablets once daily
$46.00 31 in stock Semaglutide is a man-made peptide that mimics the appearance of a natural hormone, GLP-1, within the body
It mimics a hormone your body already makes to slow digestion and reduce appetite, making it a powerful tool for both lasting weight loss and type 2 diabetes management
This directly addresses the current endpoint gap
Olympia Pharmaceuticals, which entered the GLP-1 market just 18 months ago, has seen demand surge by 15-20%
GLP-1 receptor activation reduces systemic inflammation, improves endothelial function, reduces arterial plaque progression, and lowers blood pressure